K991698 is an FDA 510(k) clearance for the REDI-TEST PCP. Classified as Enzyme Immunoassay, Phencyclidine (product code LCM).
Submitted by Redwood Biotech, Inc. (Mountian View, US). The FDA issued a Cleared decision on August 25, 1999 after a review of 99 days - within the typical 510(k) review window.
This device falls under the Toxicology FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Toxicology review framework, consistent with the majority of Class II 510(k) submissions.
View all Redwood Biotech, Inc. devices